DCAF17 Antibodies

Santa Cruz Biotechnology features a diverse variety of DCAF17 monoclonal antibodies for research focused on understanding DCAF17's role in cellular processes. DCAF17 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).DCAF17, or DDB1 and CUL4 associated factor 17, functions as a key component of the CUL4-DDB1 E3 ubiquitin ligase complex, which regulates protein degradation and maintains cellular homeostasis. DCAF17 participates in numerous biological processes, including DNA damage response, cell cycle regulation, and transcriptional control. Research has shown DCAF17's significance in proper cellular function and stress response. Investigating DCAF17 mechanisms can advance understanding of its role in cancer and neurodegenerative disorders. Current studies continue to reveal new aspects of DCAF17's cellular functions and disease associations. Ongoing research highlights DCAF17's importance in maintaining cellular health and regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DCAF17's role in human health and disease.